Open AccessP1629: ADMINISTRATION OF CONVALESCENT PLASMA FOR THE TREATMENT OF SEVERE COVID‐19: RESULTS OF A MULTICENTER PHASE II TRIAL
Author(s) -
Thomopoulos T.,
Bouchla A.,
Antoniadou A.,
Terpos E.,
Politou M.,
Stamoulis K.,
Koromboki E.,
Papageorgiou S.,
Kotanidou A.,
Kalomenidis I.,
Jahaj E.,
Grigoropoulou S.,
Pagoni M.,
Grouzi E.,
Poulakou G.,
Trontzas I.,
Labropoulou S.,
Mentis A.,
Bamias A.,
Tsiodras S.,
Dimopoulos M.A.,
Pappa V.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849372.14120.8e
Subject(s) - medicine , clinical endpoint , covid-19 , titer , convalescent plasma , retrospective cohort study , pandemic , clinical trial , antibody , immunology , disease , infectious disease (medical specialty)